Industry must avoid return to "dark days" of national laws
This article was originally published in Clinica
Executive Summary
Industry should become more involved in work on the review of the Medical Devices Directive (MDD) and play a partnership role, rather than act as an "adversary".That is the view of industry expert Jaap Laufer*, who told Clinica of his concerned that the leading competent authorities in Europe are drawing up a list of changes which "may lead to a return to the dark days of re-nationlisation of devices market approval" and is calling for industry to add its voice to balance discussions.
You may also be interested in...
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.